Anesthetix has indicated it plans to use the new capital to “enhance the level of service it provides its customers and clinical associates, and to further develop its infrastructure and depth of management support,” according to a press release.
“We’re specialists in helping our hospital and ASC customers achieve operational efficiency,” said Tushar Ramani, MD, Anesthetix’s chief operating officer, in the release. “With this strategically planned investment in our own infrastructure and operations, we’re able to bring more resources to the task.”
Under the arrangement, Mark deLaar, a principal at Summit Partners, and Tom Jennings, a managing director at Summit Partners, join the Anesthetix board of directors.
“As a market-leading, rapidly growing, profitable healthcare service company with an outstanding management team and a large addressable market, Anesthetix exemplifies the type of company that Summit Partners seeks for its investments,” deLaar said in the release.
For more information about Summit Partners, click here.
